Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02759588
Title GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Genelux Corporation
Indications

ovarian clear cell carcinoma

endometrioid ovary carcinoma

ovarian serous carcinoma

ovarian carcinoma

Therapies

GL-ONC1

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.